Mono Pharmacare Ltd
MONOPHARMAMono Pharmacare Ltd
MONOPHARMAConsumer DiscretionaryRetail - Speciality
SmallcapWith a market cap of ₹70 cr, stock is ranked 3,083
High RiskStock is 5.00x as volatile as Nifty
39.950.00% (+0.00)
39.950.00% (+0.00)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 5.16 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
41.39 | 7.73 | 0.48% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Mono Pharmacare is a distributor and supplier of pharmaceutical products and medicines, providing an extensive array of healthcare products, antibiotics, and more.
Peers
Compare with peersAditya Vision Ltd
PE Ratio
81.26
1Y Return
119.78%
Buy Reco %
100.00
Landmark Cars Ltd
PE Ratio
47.66
1Y Return
11.64%
Buy Reco %
100.00
Competent Automobiles Company Ltd
PE Ratio
12.03
1Y Return
77.20%
Buy Reco %
—
Bhatia Communications & Retail (India) Ltd
PE Ratio
34.22
1Y Return
49.05%
Buy Reco %
—
Fonebox Retail Ltd
PE Ratio
59.32
1Y Return
4.76%
Buy Reco %
—
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Earnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
Financial Year | FY 2023 | FY 2024 | TTM | |||
---|---|---|---|---|---|---|
Total Revenue | 33.15 | 122.44 | — | |||
Raw Materials | 55.83 | 116.01 | — | |||
Power & Fuel Cost | 0.01 | |||||
Employee Cost | 0.75 | |||||
Selling & Administrative Expenses | 0.79 | |||||
Operating & Other expenses | -26.54 | |||||
EBITDA | 2.31 | 6.43 | — | |||
Depreciation/Amortization | 0.05 | 0.12 | — | |||
PBIT | 2.26 | 6.31 | — | |||
Interest & Other Items | 0.93 | 3.08 | — | |||
PBT | 1.33 | 3.23 | — | |||
Taxes & Other Items | 0.38 | 0.79 | — | |||
Net Income | 0.95 | 2.44 | — | |||
EPS | 0.77 | 1.58 | — | |||
DPS | 0.00 | 0.00 | — | |||
Payout ratio | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Consumer DiscretionaryRetail - SpecialityCompare valuation on Screener
Consumer DiscretionaryRetail - Speciality
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Mono Pharmacare Ltd | 28.93 | 5.16 | — |
Aditya Vision Ltd | 81.26 | 12.87 | 0.29% |
Landmark Cars Ltd | 47.66 | 5.66 | 0.22% |
Competent Automobiles Company Ltd | 12.03 | 1.07 | — |
Price Comparison
Compare MONOPHARMA with any stock or ETFCompare MONOPHARMA with any stock or ETF
MONOPHARMA
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 2.63%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Aug 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MONOPHARMA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant